Viral gene delivery vectors: the next generation medicines for immune-related diseases

References

• Alippe Y, Mbalaviele G. Omnipresence of inflammasome activities in inflammatory bone diseases. Semin Immunopathol. 2019;41(5):607–18. doi:10.1007/s00281-019-00753-4.
   PubMed Web of Science ®Google Scholar
• Attanasio J, Wherry EJ. Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity. 2016;44(5):1052–68. doi:10.1016/j.immuni.2016.04.022.
   PubMed Web of Science ®Google Scholar
• Abbas A. Basic Immunology: functions and disorders of the immune system. 6th ed. Elsevier; 2019. p. 1–320.
   Google Scholar
• Medzhitov R, Janeway CA. Decoding the Patterns of Self and Nonself by the Innate Immune System. Science. 2002;296:298–300. doi:10.1126/science.1068883.
   PubMed Web of Science ®Google Scholar
• Ramos PS, Shedlock AM, Langefeld CD. Genetics of autoimmune diseases: insights from population genetics. J Hum Genet. 2015;60:657–64. doi:10.1038/jhg.2015.94.
   PubMed Web of Science ®Google Scholar
• Goris A, Liston A. The Immunogenetic Architecture of Autoimmune Disease. Cold Spring Harb Perspect Biol. 2012;4(3):a007260–0. doi:10.1101/cshperspect.a007260.
   PubMed Web of Science ®Google Scholar
• Nathan C, Ding A. Nonresolving Inflammation. Cell. 2010;140(6):871–82. doi:10.1016/j.cell.2010.02.029.
   PubMed Web of Science ®Google Scholar
• de Haan P, Klein HC, ‘T Hart BA. Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy. Front Psychiatry. 2017;8:158–11. doi:10.3389/fpsyt.2017.00046.
   PubMed Web of Science ®Google Scholar
• Altmann DM. Neuroimmunology and neuroinflammation in autoimmune, neurodegenerative and psychiatric disease. Immunology. 2018;154(2):167–68. doi:10.1111/imm.12943.
   PubMed Web of Science ®Google Scholar
• Sima P, Vannucci L, Vetvicka V. Atherosclerosis as autoimmune disease. Ann Transl Med. 2018;6(7):116–6. doi:10.21037/atm.2018.02.02.
   PubMed Web of Science ®Google Scholar
• Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol. 2012;92(5):959–75. doi:10.1189/jlb.0212100.
   PubMed Web of Science ®Google Scholar
• Winer S, Winer DA. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol and Cell Biol. 2012;90(8):755–62. doi:10.1038/icb.2011.110.
   PubMed Web of Science ®Google Scholar
• Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Exp Rev Clin Immunol. 2014;8(3):285–92. doi:10.1586/eci.12.7.
   Web of Science ®Google Scholar
• Wen Z, Fiocchi C. Inflammatory Bowel Disease: autoimmune or Immune-mediated Pathogenesis? Clin and Devel Immunol. 2004;11(3–4):195–204. doi:10.1080/17402520400004201.
   PubMedGoogle Scholar
• Serra P, Santamaria P. Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases. Eur J Immunol. 2018;48(5):751–56. doi:10.1002/eji.201747059.
   PubMed Web of Science ®Google Scholar
• Steinman L, Ho PP, Robinson WH, Utz PJ, Villoslada P. Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity. Curr Opin Immunol. 2019;61:46–53. doi:10.1016/j.coi.2019.07.011.
   PubMed Web of Science ®Google Scholar
• Benvenuto M, Mattera R, Masuelli L, Tresoldi I, Giganti MG, Frajese GV, Manzari V, Modesti A, Bei R. The crossroads between cancer immunity and autoimmunity: antibodies to self-antigens. Front Biosci. 2017;22:1289–329. doi:10.2741/4545.
   PubMed Web of Science ®Google Scholar
• Vossenaar ER, van Venrooij WJ. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther. 2004;6:107–11. doi:10.1186/ar1184.
   PubMedGoogle Scholar
• Consort RK, Perez CR, Del Rosário Flores RD,CME, Trincani BI, da Silva CL, Eliete B, Guerra MC, Eleonora K. Immunization with plasmids encoding M2 acetylcholine muscarinic receptor epitopes impairs cardiac function in mice and induces autophagy in the myocardium. Autoimmunity. 2018;1–13.
   Web of Science ®Google Scholar
• Schlüter A, Horstmann M, Diaz-Cano S, Plöhn S, Stähr K, Mattheis S, Oeverhaus M, Lang S, Flögel U, Berchner-Pfannschmidt U, et al. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves’ orbitopathy. Clin and Exp Immunol. 2017;191(3):255–67. doi:10.1111/cei.13075.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptor and RIG-1-like receptor signaling. Ann New York Acad Sci. 2008;1143:1–20.
   PubMed Web of Science ®Google Scholar
• Milone MC, O’Doherty U. Clinical use of lentiviral vectors. Leukemia. 2018;32(7):1529–41. doi:10.1038/s41375-018-0106-0.
   PubMed Web of Science ®Google Scholar
• Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21(4):255–72. doi:10.1038/s41576-019-0205-4.
   PubMed Web of Science ®Google Scholar
• Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nature. 2010;10:753–66.
   Web of Science ®Google Scholar
• LoDuca PA, Hoffman BE, Herzog RW. Hepatic gene transfer as a means of tolerance induction to transgene products. Curr Gene Ther. 2009;9(2):104–14. doi:10.2174/156652309787909490.
   PubMed Web of Science ®Google Scholar
• Keeler GD, Markusic DM, Hoffman BE. Liver Induced Transgene Tolerance with AAV Vectors. Cell Immunol. 2017;342:1–27.
   Web of Science ®Google Scholar
• Recino A, Gan SU, Sia KC, Sawyer Y, Trendell J, Kay R, Gribble FM, Reimann F, Foale R, Notaridou M, et al. Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice. Gene Ther. 2019;26:1–17.
   PubMed Web of Science ®Google Scholar
• Tengvall S, Eneljung T, Jirholt P, Turesson O, Wing K, Holmdahl R, Kihlberg J, Stern A, Mårtensson I-L, Henningsson L, et al. Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis. PLoS ONE. 2016;11:e0154630–21. doi:10.1371/journal.pone.0154630.
   PubMed Web of Science ®Google Scholar
• Keeler GD, Kumar S, Palaschak B, Silverberg EL, Markusic DM, Jones NT, Hoffman BE. Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis. Mol Ther. 2018;26(1):173–83. doi:10.1016/j.ymthe.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Hoffman BE, Herzog RW. Coaxing the liver into preventing autoimmune disease in the brain. J Clin Invest. 2008;118:1–3.
   Web of Science ®Google Scholar
• Hüser D, Khalid D, Lutter T, Hammer E-M, Weger S, Heßler M, Kalus U, Tauchmann Y, Hensel-Wiegel K, Lassner D, et al. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence. J Virol. 2017;91:754–13. doi:10.1128/JVI.02137-16.
   Web of Science ®Google Scholar
• Boutin SS, Monteilhet VV, Veron PP, Leborgne CC, Benveniste OO, Montus MFM, Masurier CC. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Audio, Transactions IRE Prof Group. 2010;21:704–12.
   Google Scholar
• Martino AT, Markusic DM. Immune response mechanisms against AAV vectors in animal models. Mol Ther Methods Clin Dev. 2019;17:1–22.
   Web of Science ®Google Scholar
• Chen L. Tsai. SV40 Hijacks Cellular Transport, Membrane Penetration, and Disassembly Machineries to Promote Infection. Viruses. 2019;11:917–11. doi:10.3390/v11100917.
   PubMed Web of Science ®Google Scholar
• Toscano MG, de Haan P. How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours. Front Immunol. 2018;9:1–9. doi:10.3389/fimmu.2018.01160.
   PubMed Web of Science ®Google Scholar
• Toscano MG, van der Velden J, van der Werf S, Odijk M, Roque A, Camacho-Garcia RJ, Herrera-Gomez IG, Mancini I, de Haan P. Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies. Mol Ther Methods Clin Dev. 2017;6:124–34. doi:10.1016/j.omtm.2017.06.007.
   PubMed Web of Science ®Google Scholar
• López-Lázaro M. The stem cell division theory of cancer. Crit Rev Oncol/Hematol. 2018;123:95–113. doi:10.1016/j.critrevonc.2018.01.010.
   PubMed Web of Science ®Google Scholar
• Dashti S, Taherian-Esfahani Z. Cellular immune responses against cancer-germline genes in cancers. Hum Antibodies. 2019;12:1–8.
   Google Scholar
• Vigneron N. Human Tumor Antigens and Cancer Immunotherapy. BioMed Res Internatl. 2015;2015:1–17. doi:10.1155/2015/948501.
   Web of Science ®Google Scholar
• Schumacher TN, Scheper W, Kvistborg P. Cancer Neoantigens. Annu Rev Immunol. 2019;37:173–200. doi:10.1146/annurev-immunol-042617-053402.
   PubMed Web of Science ®Google Scholar
• Achinger-Kawecka J, Valdes-Mora F, Luu P-L, Giles KA, Caldon CE, Qu W, Nair S, Soto S, Locke WJ, Yeo-Teh NS, et al. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer. Nat Commun. 2020;11(1):1–17. doi:10.1038/s41467-019-14098-x.
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–84. doi:10.1101/gad.314617.118.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J. 2012;40(6):1489–95. doi:10.1183/09031936.00222911.
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56–61. doi:10.1126/science.aaa8172.
   PubMed Web of Science ®Google Scholar
• Kim TK, Herbst RS, Defining CL. Understanding Adaptive Resistance in Cancer Immunotherapy. Trends Immunol. 2018;39:624–31. doi:10.1016/j.it.2018.05.001.
   PubMed Web of Science ®Google Scholar
• Restifo NP, Smyth MJ, Snyder A. Acquired resistance to immunotherapy and future challenges. Nat Rev Cancer. 2016;16:121–26. doi:10.1038/nrc.2016.2.
   PubMed Web of Science ®Google Scholar
• Overwijk WW. Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant. Curr Opin Immunol. 2017;47:103–09. doi:10.1016/j.coi.2017.07.015.
   PubMed Web of Science ®Google Scholar
• Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines. 2019;4(1):1–10. doi:10.1038/s41541-019-0103-y.
   PubMedGoogle Scholar
• Lawler SE, Speranza M-C, Cho C-F, Chiocca EA. Oncolytic Viruses in Cancer Treatment. JAMA Oncol. 2017;3(6):841–49. doi:10.1001/jamaoncol.2016.2064.
   PubMed Web of Science ®Google Scholar
• Peters C, Grandi P, Nigim F. Updates on Oncolytic Virus Immunotherapy for Cancers. Molecular Therapy. Oncolytics. 2019;12:259–62. doi:10.1016/j.omto.2019.01.008.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, Liu M, Zhou N, Lv J, Tang K, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020;5:eaax7969. doi:10.1126/sciimmunol.aax7969.
   PubMed Web of Science ®Google Scholar
• Lane C, Leitch J, Tan X, Hadjati J, Bramson JL, Wan Y. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res. 2004;64:1509–14.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci USA. 1999;96:5340–42. doi:10.1073/pnas.96.10.5340.
   PubMed Web of Science ®Google Scholar
• Rayner JO, Dryga SA, Kamrud KI. Alphavirus vectors and vaccination. Rev Med Virol. 2002;12:279–96. doi:10.1002/rmv.360.
   PubMed Web of Science ®Google Scholar
• Larocca C, Schlom J. Viral Vector-Based Therapeutic Cancer Vaccines. The Cancer J. 2011;17:359–71. doi:10.1097/PPO.0b013e3182325e63.
   PubMed Web of Science ®Google Scholar
• Wold WSM, Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther. 2013;13:421–33. doi:10.2174/1566523213666131125095046.
   PubMed Web of Science ®Google Scholar
• Lachmann R. Herpes simplex virus‐based vectors. Int J Exp Pathol. 2004;85:177–90. doi:10.1111/j.0959-9673.2004.00383.x.
   PubMed Web of Science ®Google Scholar
• Guo ZS, Lu B, Guo Z, Giehl E, Feist M, Dai E, Liu W, Storkus WJ, He Y, Liu Z, et al. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics. J Immunother Cancer. 2019;7:1–21. doi:10.1186/s40425-018-0495-7.
   PubMed Web of Science ®Google Scholar
• Lundstrom K. Plasmid DNA-based Alphavirus Vaccines. Vaccines. 2019;7(1):29–10. doi:10.3390/vaccines7010029.
   Web of Science ®Google Scholar
• Morse MA, Hobeika AC, Osada T, Berglund P, Hubby B, Negri S, Niedzwiecki D, Devi GR, Burnett BK, Clay TM, et al. An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. J Clin Invest. 2010;120(9):3234–41. doi:10.1172/JCI42672.
   PubMed Web of Science ®Google Scholar
• Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP, Israel R, Scher HI, Morris S. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine. 2013;31(6):943–49. doi:10.1016/j.vaccine.2012.11.096.
   PubMed Web of Science ®Google Scholar
• Singh A. An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunol Immunother. 2019;68:849–59. doi:10.1007/s00262-018-2276-z.
   PubMed Web of Science ®Google Scholar
• de Meijer C, Wouterse B, Polder J, Koopmanschap M. The effect of population aging on health expenditure growth: a critical review. Eur J Ageing. 2013;10:353–61. doi:10.1007/s10433-013-0280-x.
   PubMed Web of Science ®Google Scholar